Navigation Links
Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
Date:2/3/2010

ed during the STI period; however, the return of the virus was delayed. CD4+ T-cells and ZFN-modified T-cells were found to be stable and were observed in the GALT.  The data suggest that the modified cells were able to expand and were circulating and trafficking normally in the body.
  • Initiation of Phase 1 Clinical Trial to Evaluate ZFN-Therapeutic for the Treatment of Glioblastoma: Sangamo announced in January 2010 that the US Food and Drug Administration had reviewed and accepted an Investigational New Drug application to initiate this open-label, multi-dosing Phase 1 clinical trial. The Phase 1 glioblastoma trial is being initiated by Sangamo's collaborators at City of Hope and is designed to evaluate the safety and tolerability of a modified CD8+ cytotoxic T lymphocyte (CTL) product that has been made resistant to glucocorticoid steroids using Sangamo's ZFN-based technology.  The study will accrue subjects with recurrent/refractory malignant glioblastoma multiforme.  
  • Sangamo Scientists and Collaborators Receive Grant Funding from Several Sources to Develop ZFP Therapeutic Candidates:
    • Grand Challenges Explorations Grant from the Bill & Melinda Gates Foundation was awarded to Sangamo scientists in May 2009.  The grant of $100,000 supports an innovative global health research project conducted by Sangamo scientists and titled "Zinc Finger Nucleases for In Vivo Treatment of HIV Infection."
    • Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation was awarded to Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Resea
      '/>"/>

    SOURCE Sangamo BioSciences, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
    2. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
    3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
    4. Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
    5. Sangamo Announces Pricing of Public Offering of Common Stock
    6. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
    7. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
    8. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
    9. Sangamo BioSciences Reports Second Quarter 2009 Financial Results
    10. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
    11. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... that power our laptops and electric vehicles could store ... with the help of a sponge-like silicon material. ... graphite traditionally used in one of the battery,s electrodes, ... storage capacity of graphite. A paper describing the material,s ... in Nature Communications . , "Silicon has long ...
    (Date:7/10/2014)... 1960s, theatergoers have shelled out for crude 3-D ... their viewing experience. These basic devices, used to ... reality, may soon be rendered obsolete with the ... Aviv University researchers. , TAU doctoral students Yuval ... highly efficient holography based on nanoantennas that could ...
    (Date:7/10/2014)... two universities and NPL collaborate to bring together their ... their complementary academic strengths., Working with BIS and NPL ... priorities of the UK. The establishment of a Graduate ... students, will provide a pipeline of skilled researchers. Working ... Laboratory will be grown through the creation of a ...
    (Date:1/15/2014)... Nobel laureate Herbert Kroemer famously observed, referring to ... junctures where layers of different materials meet. In ... layers of metal oxides are becoming increasingly prominent, ... high-temperature superconductors, ferroelectrics and multiferroics. Realizing the vast ...
    Breaking Biology Technology:Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 2Universities of Surrey and Strathclyde selected as strategic partners in the future operation of the National Physical Laboratory 3A deeper look at interfaces 2
    ... , CALGARY and CAMBRIDGE, MA , ... leading developer of biosimilar drug candidates, high-value proteins and oils ... Rick Pierce has joined the Company as President of ... office in Cambridge, Massachusetts which will offer the ...
    ... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical ... into a purchase agreement to sell $3.9 million of its ... public offering.   , , ... the terms of the purchase agreement, PharmAthene will sell an aggregate of ...
    ... 20, 2010 Today at the XVIII International AIDS ... Microbicide Advocates (IRMA) and thousands of other HIV advocates ... the quest for new HIV prevention technologies. Researchers announced ... reduce a woman,s risk of being infected with HIV ...
    Cached Biology Technology:SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents 2SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents 3SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents 4PharmAthene Announces $3.9 Million Registered Direct Offering 2PharmAthene Announces $3.9 Million Registered Direct Offering 3HIV prevention science scores a victory -- the gel works! 2HIV prevention science scores a victory -- the gel works! 3
    (Date:7/10/2014)... NORTHFIELD, Ill. , July 9, 2014 /PRNewswire-USNewswire/ ... record (EHR), spurred in large part by meaningful ... way health care providers interact with laboratory information. ... well-versed in the field of clinical informatics in ... care. To address the educational needs ...
    (Date:7/10/2014)... the main organization of the International Science and Business ... group of researchers, led by professor Won Do Heo, ... optogenetics that can remotely control specific receptors by light. ... has succeeded with neuronal differentiation inducement. , The most ... only light to activate neuronal functions without the need ...
    (Date:7/10/2014)... oil found in your popcorn or soap might not be ... worse, according to an analysis in the Cell Press journal ... demand for vegetable oil has already led to the conversion ... for orangutans in particular. If guidelines are not put in ... industrial plantations from Asia into Africa will be bad news ...
    Breaking Biology News(10 mins):New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4New optogenetic tool for controlling neuronal signalling by blue light 2Hunger for vegetable oil means trouble for Africa's great apes 2
    ... 3, 2008) According to a report released today ... rare waterbirds from Cambodias famed Tonle Sap region have ... single team of park rangers to provide 24-hour protection ... employing former hunters and egg collectors to protect and ...
    ... Continuous oral contraceptives may be more effective than the ... according to researchers. They say that the continuous pill ... changes. "We have provided a biological proof of concept ... uterus are suppressed better and quicker with the continuous ...
    ... a new technique for turning embryonic stem cells into ... breakthrough in the quest to find new treatments for ... colleagues at the University of Sheffield, were able to ... an important protein known as a transcription factor. ...
    Cached Biology News:Continuous oral contraceptives better at easing pain, bleeding 2Continuous oral contraceptives better at easing pain, bleeding 3Stem cell breakthrough offers diabetes hope 2
    ... 50ml PYREX Delong style shaker flasks have ... greater agitation of solutions to improve oxygen ... or reciprocating shakers. The long neck reduces ... closures. Their uniform wall thickness provides the ...
    ... Analysis of large numbers of samples may be ... system, which requires minimum operator attention. ... PowerStream software and interface CE 4900. The ... operates in Windows XP and Windows 98 and ...
    ... cultured in Minimum Essential Medium (Eagle) with 2 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
    Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)...
    Biology Products: